Btk inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
MERCK SHARP & DOHME CORP.
C A A A C A A
C07D A61K A61P A61K C07D A61P A61K
inventional inventional inventional inventional inventional inventional inventional
Joseph Arto D. Jian Rajan Ronald M.
Kozlowski Krikorian Liu Anand Kim